Please use this identifier to cite or link to this item:
Scopus Web of ScienceĀ® Altmetric
Type: Journal article
Title: Aspirin: How low is low dose?
Author: Lloyd, J.
Bochner, F.
Citation: Australian Prescriber, 1996; 19(3):79-81
Publisher: Australian Prescriber
Issue Date: 1996
ISSN: 0312-8008
Statement of
John Lloyd, Felix Bochner
Abstract: Aspirin reduces the risk of non-fatal stroke, non-fatal myocardial infarction and vascular death in patients at high risk of arterial thrombosis. Platelet function is inhibited by doses of 40-160 mg daily. In clinical trials performed before 1985, doses of 500-1500 mg daily were found to be effective. Since 1985, low doses have been evaluated and a meta-analysis has shown that daily doses of 75-150 mg are as effective as the previously used higher doses. The risk of adverse effects is dose-dependent above 75 mg daily. The maximum benefit:risk ratio is likely to be achieved with doses of 75-150 mg daily. In Australia, this is best achieved by either a single 100 mg tablet or half a 300 mg tablet taken daily.
Keywords: formulation
clinical trials
adverse effects
platelet function
DOI: 10.18773/austprescr.1996.070
Published version:
Appears in Collections:Aurora harvest 2
Pharmacology publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.